Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.

Area of Science:

• Molecular biology
• Immunology
• Neuroscience

Background:

• Adenosine deaminase acting on RNA 1 (ADAR1) catalyzes dsRNA adenosine-to-inosine editing.
• ADAR1 has two isoforms: p150 and p110, with distinct functions.
• The p150 isoform's N-terminal Z-DNA/RNA-binding domain α (Zα) is critical for its immune-regulatory role.

Purpose of the Study:

• To investigate the role of ADAR1 p150's Zα domain in RNA editing and immune response.
• To determine if Zα-mediated RNA editing prevents MDA5 pathway activation.
• To explore the link between Zα mutations, ADAR1 function, and Aicardi-Goutières syndrome (AGS).

Main Methods:

• Comparing RNA editing activity and MDA5 activation between ADAR1 p150 and p110 isoforms.
• Utilizing Zα-mutated mouse models, including one with a W197A mutation affecting Z-RNA binding.
• Analyzing type I interferon responses in mutant mice.

Main Results:

• ADAR1 p150, but not p110, prevents MDA5 activation through RNA editing.
• Mutations in the Zα domain lead to MDA5-dependent type I interferon responses.
• A W197A mutation in Zα, inhibiting Z-RNA binding, causes AGS-like encephalopathy.

Conclusions:

• Z-RNA binding by ADAR1 p150's Zα domain is essential for specific RNA editing.
• This editing prevents aberrant MDA5 activation and associated autoimmune/encephalopathic conditions.
• ADAR1 p150's Zα domain plays a vital role in maintaining immune homeostasis and preventing neurological disorders.